Advertisement
Screener

GSK plc (GLAXF) Form 6-K: Report of foreign private issuer, 2018

2.1 / 5 stars · 17/40 Roast Me

Add as a preferred source on Google

GSK plc Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2018-12-20: Form 6-K; Period of report 2018-12-20; Description DIRECTOR/PDMR SHAREHOLDING; Document a1928l.htm.
  • 2018-12-19: Form 6-K; Period of report 2018-12-19; Description GSK AND PFIZER CREATE NEW CONSUMER HEALTHCARE JV; Document a9436k.htm.
  • 2018-12-14: Form 6-K; Period of report 2018-12-14; Description GSK COMMENCES TENDER OFFER FOR TESARO INC.; Document a5671k.htm.
  • 2018-12-12: Form 6-K; Period of report 2018-12-12; Description DIRECTOR/PDMR SHAREHOLDING; Document a3071k.htm.
FiledFormPeriod of reportDescriptionDocument
2018-12-206-K2018-12-20DIRECTOR/PDMR SHAREHOLDINGa1928l.htm
2018-12-196-K2018-12-19GSK AND PFIZER CREATE NEW CONSUMER HEALTHCARE JVa9436k.htm
2018-12-146-K2018-12-14GSK COMMENCES TENDER OFFER FOR TESARO INC.a5671k.htm
2018-12-126-K2018-12-12DIRECTOR/PDMR SHAREHOLDINGa3071k.htm
2018-12-046-K2018-12-04DIRECTOR/PDMR SHAREHOLDINGa3711j.htm
2018-12-036-K2018-12-03TOTAL VOTING RIGHTSa2624j.htm
2018-12-036-K2018-12-03GSK REACHES AGREEMENT TO ACQUIRE TESAROa2465j.htm
2018-12-036-K2018-12-03GSK TO DIVEST HORLICKS TO UNILEVERa1972j.htm
2018-11-296-K2018-11-29DIRECTOR/PDMR SHAREHOLDINGa9605i.htm
2018-11-296-K2018-11-29GSK - UPDATE ON REVIEW OF HORLICKSa9292i.htm
2018-11-276-K2018-11-27BLOCK LISTING INTERIM REVIEWa6695i.htm
2018-11-236-K2018-11-23GSK PUBLISHES 2019 DIVIDEND DATESa2387i.htm
2018-11-136-K2018-11-13DIRECTOR/PDMR SHAREHOLDINGa0934h.htm
2018-11-136-K2018-11-13BLOCKLISTING APPLICATIONa0307h.htm
2018-11-086-K2018-11-08DIRECTOR DECLARATIONa8078g.htm
2018-11-026-K2018-11-02DIRECTOR/PDMR SHAREHOLDINGa2472g.htm
2018-11-016-K2018-11-01TOTAL VOTING RIGHTSa0706g.htm
2018-10-316-K2018-10-313RD QUARTER RESULTSa8811f.htm
2018-10-316-K2018-10-31VIIV POSITIVE PHIII RESULTS WITH FOSTEMSAVIRa8922f.htm
2018-10-306-K2018-10-30VIIV: POSITIVE DATA FOR LONG-ACTING INJECTABLEa7529f.htm
2018-10-296-K2018-10-29VIIV - THREE-YEAR DATA FOR LONG-ACTING INJECTABLEa5264f.htm
2018-10-186-K2018-10-18VIIV SUBMITS HIV 2DR REGULATORY APPLICATION TO FDAa5236e.htm
2018-10-186-K2018-10-18DIRECTOR/PDMR SHAREHOLDINGa4656e.htm
2018-10-176-K2018-10-17DIRECTOR/PDMR SHAREHOLDINGa4029e.htm
2018-10-176-K2018-10-17DIRECTOR/PDMR SHAREHOLDINGa4021e.htm
2018-10-176-K2018-10-17DIRECTOR/PDMR SHAREHOLDINGa3491e.htm
2018-10-166-K2018-10-16DIRECTOR/PDMR SHAREHOLDINGa2530e.htm
2018-10-166-K2018-10-16DIRECTOR/PDMR SHAREHOLDINGa1791e.htm
2018-10-166-K2018-10-16DIRECTOR/PDMR SHAREHOLDINGa1817e.htm
2018-10-106-K2018-10-10DIRECTOR/PDMR SHAREHOLDINGa6436d.htm
2018-10-016-K2018-10-01TOTAL VOTING RIGHTSa5614c.htm
2018-09-276-K2018-09-27DIRECTOR/PDMR SHAREHOLDINGa2277c.htm
2018-09-216-K2018-09-21CHMP RECOMMENDS EXPANSION OF TRELEGY COPD LABELa5753b.htm
2018-09-146-K2018-09-14VIIV SUBMITS HIV 2DR REGULATORY APPLICATION TO EMAglaxosmithklinemasterform.htm
2018-09-126-K2018-09-12DIRECTOR/PDMR SHAREHOLDINGa6119a.htm
2018-09-106-K2018-09-10GSK RECEIVES CRL FROM FDA FOR MEPOLIZUMAB IN COPDa2486a.htm
2018-09-106-K2018-09-10NEW ANALYSIS ON EFFICACY OF ANTI-IL5 BIOLOGICS SEAa2443a.htm
2018-09-076-K2018-09-07DIRECTOR/PDMR SHAREHOLDINGa1688a.htm
2018-09-076-K2018-09-07DIRECTOR/PDMR SHAREHOLDINGa1678a.htm
2018-09-046-K2018-09-04TOTAL VOTING RIGHTSa6291z.htm
2018-08-306-K2018-08-30GSK PUBLISHES Q4 2018 DIVIDEND DATESa3220z.htm
2018-08-306-K2018-08-30EU APPROVE NUCALA IN SEVERE ASTHMA IN CHILDRENa2480z.htm
2018-08-246-K2018-08-24DIRECTOR/PDMR SHAREHOLDINGa8270y.htm
2018-08-156-K2018-08-15POSITIVE HEADLINE RESULTS FOR VIIV HC ATLAS STUDYa8544x.htm
2018-08-106-K2018-08-10DIRECTOR/PDMR SHAREHOLDINGa5161x.htm
2018-08-086-K2018-08-08DIRECTOR/PDMR SHAREHOLDINGa2232x.htm
2018-08-076-K2018-08-07IAIN MACKAY APPOINTED GSK CHIEF FINANCIAL OFFICERa0260x.htm
2018-08-026-K2018-08-02TOTAL VOTING RIGHTSa6396w.htm
2018-07-316-K2018-07-31DIRECTOR/PDMR SHAREHOLDINGa3705w.htm
2018-07-316-K2018-07-31DIRECTOR/PDMR SHAREHOLDINGa3765w.htm
2018-07-276-K2018-07-27DIRECTOR/PDMR SHAREHOLDINGa0656w.htm
2018-07-276-K2018-07-27CHMP RECOMMEND NUCALA FOR SEVERE ASTHMA CHILDRENa0533w.htm
2018-07-256-K2018-07-25DIRECTOR/PDMR SHAREHOLDINGa7761v.htm
2018-07-256-K2018-07-25GSK AND 23ANDME AGREEMENTa7182v.htm
2018-07-256-K2018-07-252ND QUARTER RESULTSa7337v.htm
2018-07-246-K2018-07-24VIIV ANNOUNCES JULUCA 100 WEEK DATA AT AIDS 2018a5082v.htm
2018-07-246-K2018-07-24VIIV SHOWS POSITIVE PHIII DATA ON TWO-DRUG COMBOa5066v.htm
2018-07-196-K2018-07-19DIRECTOR/PDMR SHAREHOLDINGa2174v.htm
2018-07-176-K2018-07-17DIRECTOR/PDMR SHAREHOLDINGa9494u.htm
2018-07-176-K2018-07-17DIRECTOR/PDMR SHAREHOLDINGa9428u.htm
2018-07-176-K2018-07-17DIRECTOR/PDMR SHAREHOLDINGa9418u.htm
2018-07-166-K2018-07-16DIRECTOR/PDMR SHAREHOLDINGa7833u.htm
2018-07-166-K2018-07-16DIRECTOR/PDMR SHAREHOLDINGa7535u.htm
2018-07-136-K2018-07-13DIRECTOR/PDMR SHAREHOLDINGa6504u.htm
2018-07-136-K2018-07-13DIRECTOR/PDMR SHAREHOLDINGa6505u.htm
2018-07-116-K2018-07-11DIRECTOR/PDMR SHAREHOLDINGa3478u.htm
2018-07-026-K2018-07-02TOTAL VOTING RIGHTSa2901t.htm
2018-06-146-K2018-06-14POSITIVE HEADLINE RESULTS FOR VIIV GEMINI STUDIESa3781r.htm
2018-06-126-K2018-06-12DIRECTOR/PDMR SHAREHOLDINGa1781r.htm
2018-06-126-K2018-06-12GSK ANNOUNCES CHANGES TO CORPORATE EXECUTIVE TEAMa1441r.htm
2018-06-016-K2018-06-01GSK COMPLETES CONSUMER HEALTHCARE BUYOUTa0515q.htm
2018-06-016-K2018-06-01TOTAL VOTING RIGHTSa0028q.htm
2018-05-296-K2018-05-29GSK ONCE-DAILY SINGLE INHALER TRIPLE THERAPY COPDa4399p.htm
2018-05-216-K2018-05-21VIIV GRANTED EU MARKETING AUTHORISATION FOR JULUCAa7229o.htm
2018-05-156-K2018-05-15DIRECTOR/PDMR SHAREHOLDINGa1572o.htm
2018-05-156-K2018-05-156-Kd587303d6k.htm
2018-05-116-K2018-05-11DIRECTOR/PDMR SHAREHOLDINGa8659n.htm
2018-05-106-K2018-05-10BLOCK LISTING INTERIM REVIEWa7285n.htm
2018-05-106-K2018-05-106-Kd580680d6k.htm
2018-05-096-K/A2018-05-09DIRECTOR/PDMR SHAREHOLDINGa5717n-6ka.htm
2018-05-096-K2018-05-09DIRECTORATE CHANGEa5232n.htm
2018-05-036-K2018-05-03RESULT OF AGMa1002n.htm
2018-05-036-K2018-05-03RESULT OF GENERAL MEETINGa0995n.htm
2018-05-016-K2018-05-01TOTAL VOTING RIGHTSa7788m.htm
2018-04-276-K2018-04-27DIRECTOR/PDMR SHAREHOLDINGa4172m.htm
2018-04-266-K2018-04-26DIRECTOR/PDMR SHAREHOLDINGa2893m.htm
2018-04-256-K2018-04-251ST QUARTER RESULTSa25-042018v4.htm
2018-04-246-K2018-04-24TRELEGY ELLIPTA EXPANDED US COPD INDICATIONa9976l.htm
2018-04-206-K2018-04-20DIRECTOR/PDMR SHAREHOLDINGa6720l.htm
2018-04-206-K2018-04-20DIRECTOR/PDMR SHAREHOLDINGa6721l.htm
2018-04-196-K2018-04-19IMPACT STUDY SHOWS BENEFITS OF TRELEGY ELLIPTAa3975l.htm
2018-04-176-K2018-04-17DIRECTOR/PDMR SHAREHOLDINGa2033l.htm
2018-04-176-K2018-04-17DIRECTOR/PDMR SHAREHOLDINGa2019l.htm
2018-04-176-K2018-04-17DIRECTOR/PDMR SHAREHOLDINGa2003l.htm
2018-04-176-K2018-04-17DIRECTOR/PDMR SHAREHOLDINGa2014l.htm
2018-04-176-K2018-04-17DIRECTOR/PDMR SHAREHOLDINGa2009l.htm
2018-04-136-K2018-04-13DIRECTOR/PDMR SHAREHOLDINGa9262k.htm
2018-04-136-K2018-04-13DIRECTOR/PDMR SHAREHOLDINGa9250k.htm
2018-04-136-K2018-04-13NOTICE OF GMa8879k.htm
2018-04-136-K2018-04-136-Kd558539d6k.htm
Advertisement